Vol. 8 No. 3 (2011)

Articles

• The Continuing Need for Drug Development and Clinical Trials in Type 2 Diabetes and its Complications: Introduction to The RDS Special Issue

  Itamar Raz, Baptist Gallwitz

  • pdf

• Physiology of Incretins in Health and Disease

  Carolyn F. Deacon, Bo Ahrén

  • pdf

• Incretin Therapy – Present and Future

  Alan J. Garber

  • pdf

• The Role of Incretin Therapy at Different Stages of Diabetes

  Simona Cernea

  • pdf

• Therapy for Obesity Based on Gastrointestinal Hormones

  Jonatan I. Bagger, Mikkel Christensen, Filip K. Knop, Tina Vilsbøll

  • pdf

• SGLT-2 Inhibitors in Development for Type 2 Diabetes Treatment

  Mithun Bhartia, Abd A. Tahrani, Anthony H. Barnett

  • pdf

• Peptides and Their Potential Role in the Treatment of Diabetes and Obesity

  Hannah C. Greenwood, Stephen R. Bloom, Kevin G. Murphy

  • pdf

• The Alpha-Cell as Target for Type 2 Diabetes Therapy

  Mikkel Christensen, Jonatan I. Bagger, Tina Vilsbøll, Filip K. Knop

  • pdf

• Cardiovascular Effects of Incretin-Based Therapies

  Michael Lehrke, Nikolaus Marx

  • pdf

• The Kidney in Type 2 Diabetes Therapy

  Hiddo J. Lambers Heerspink, Dick de Zeeuw

  • pdf

• Fatty Heart, Cardiac Damage, and Inflammation

  Maria A. Guzzardi, Patricia Iozzo

  • pdf

• GLP-1, the Gut-Brain, and Brain-Periphery Axes

  Cendrine Cabou and Rémy Burcelin

  • pdf

• Metabolic Memory and Individual Treatment Aims in Type 2 Diabetes – Outcome-Lessons Learned from Large Clinical Trials

  Cristina Bianchi, Stefano Del Prato

  • pdf